The minimum BMI for semaglutide (Wegovy) under FDA labeling is 30 without any additional conditions, or 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
We understand how the chronic stress of city living, layered on top of long COVIDs effect on your nervous system, creates a perfect storm of dysfunction
In the STEP trials, semaglutide 2.4mg weekly resulted in mean weight reductions of 1517% over 68 weeks, whilst tirzepatide in the SURPASS trials showed reductions of 1520% (Kushner et al
Another user throws away perfectly good GHK-Cu at day 20 thinking it expired
As glutathione is rapidly depleted during stress, exhaustion or sport, a normal diet is often not sufficient to cover the requirement
Without that baseline, gains will be minimal